In a recent and momentous event, a significant Memorandum of Understanding (MOU) was signed, uniting Dadvance Agarwood Solutions sdn Bhd, the Technological and Higher Education Institute of Hong Kong (THEi), and Filix Medtech HK in an exciting collaboration. This remarkable occasion attracted the presence of distinguished guests from various sectors, all coming together to witness the unfolding of a promising partnership.
The MOU signing ceremony was graced by the esteemed presence of luminaries from diverse fields. Among the honored guests were Mr. Yazrin Syakhairi Mahlan, Trade Commissioner of the Consulate General of Malaysia Trade Section (MATRADE), as well as Ms. Samantha Lee and Mr. Alan Vu from Cyberport. Adding to the prestige were Ms. Natalie Ip, Head of Sustainability at Dorsett Hospitality International (Donor of HKCMCRC), Mr. Nelson Liew – President of Business Networking Club Malaysia, Dr. Wong Wai Kong from Filix Medtech HK, Prof. Alan Lau Kin Tak – President of THEi, and Mr. David Liew – Founder & Group Managing Director of Dadvance Agarwood Solutions Sdn Bhd.
At the heart of this collaboration lies a pioneering venture – the development of agarwood products for Traditional Chinese Medicine (TCM), seamlessly integrated with traceability blockchain technology. This innovative alliance is poised to introduce a new era of safe and traceable TCM agarwood products into the Hong Kong market and beyond.
With the demand for Traditional Chinese Medicine consistently on the rise, this partnership seizes upon a golden opportunity. By merging TCM’s wisdom with cutting-edge technology, the collaboration aims to provide consumers with safe and authentic products that meet their evolving needs.
Integral to this MOU is the remarkable strength of THEi in Traditional Chinese Medicine. Leveraging its renowned expertise, THEi brings invaluable insights to the table, ensuring the products developed are deeply rooted in tradition while embracing innovation.
Standing out amidst the collaboration is Filix Medtech, an award-winning startup celebrated for its prowess in traceability, automation, and blockchain technology. This partnership capitalizes on Filix Medtech’s capabilities to infuse transparency and authenticity throughout the production process.
